How To Use Myelofibrosis In A Sentence

Causes of a high MCV include liver disease, alcohol abuse, hypothyroidism, reticulocytosis, marrow aplasia, vitamin B12 or folic acid deficiency, and myelofibrosis. You Staying Young
ZURICH— Novartis AG said Tuesday an experimental drug for the treatment of myelofibrosis, a rare form of blood cancer, met the goals of a late-stage study, which should pave the way to begin filing the drug for regulatory approvals in the second quarter. Novartis Blood-Cancer Drug Meets Goal
Abstracts already released suggest that the studies are going to point to much bigger potential for '424 beyond its lead indication myelofibrosis, which is already viewed as a blockbuster opportunity. Healthcare Sector and Stocks Analysis from Seeking Alpha
Novartis, based in Basel, Switzerland, said the study showed treatment with ruxolitinib, also known as INC424, provided a statistically significant reduction in spleen size in patients with different forms of myelofibrosis when compared with the best available therapy. Novartis Blood-Cancer Drug Meets Goal
An enlarged spleen is one of the characteristics of myelofibrosis. Novartis Blood-Cancer Drug Meets Goal

Incyte Corp.'s Jakafi pill obtained U.S. Food and Drug Administration approval Wednesday, making it the first drug approved specifically for myelofibrosis, a rare bone-marrow disease, according to the government agency. FDA Approves Incyte's Drug for Bone-Marrow Disease
The cause of myelofibrosis is unknown, and there are few treatment options. Novartis Blood-Cancer Drug Meets Goal
NEW ORLEANS ― A first-in-its class oral medication provides significant and durable relief for patients with a rare, debilitating and lethal bone marrow disorder called myelofibrosis, researchers at The University of Texas M. EurekAlert! - Breaking News
Patients with primary myelofibrosis feel fatigued, and they sometimes take an anemia drug to stimulate growth of oxygen-carrying red blood cells.
Leukemic transformation of chronic idiopathic myelofibrosis to acute lymphoblastic leukemia is rare.
The bone marrow of people with myelofibrosis is replaced by scar tissue, which can cause an enlarged spleen, anemia, decreased white blood cells and platelets. FDA Approves Incyte's Drug for Bone-Marrow Disease
*** Pharmaceuticals Novartis said an experimental drug for the treatment of myelofibrosis, a rare form of blood cancer, met the goals of a late-stage study, which should pave the way to file the drug for regulatory approval in the second quarter. Business Watch